In vitro activity of etanidazole against the protozoan parasite Trypanosoma cruzi

Memorias do Instituto Oswaldo Cruz

Volumn 99, Issue 2, 2004, Pages 233-235

  Petray, Patricia B ^a,c   Morilla, María J ^b,d   Corral, Ricardo S ^a,c   Romero, Eder L ^b  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^d Universidad Provincial del Sudoeste   (Argentina)

Author keywords

Chemotherapy; Etanidazole; Trypanosoma cruzi

Indexed keywords

ETANIDAZOLE;

AMASTIGOTE; ANIMAL CELL; ARTICLE; CELL VIABILITY; CHAGAS DISEASE; HOST CELL; MACROPHAGE; NONHUMAN; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; VERO CELL;

ANIMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 2542525296     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762004000200021     Document Type: Article

References (12)

1. Cançado JR 2002. Long term evaluation of etiological treatment of Chagas' disease with benznidazole. Rev Inst Med Trop São Paulo 44: 29-37.
2. Coleman CN, Urtasun RC, Wasserman TH, Hancock S, Harris JW, Halsey J, Hirst VK 1984. Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508. Int J Radiat Oncol Biol Phys 10: 1749-1753.
3. Filardi LS, Brener Z 1987. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used in Chagas' disease. Trans R Soc Trop Med Hyg 81: 755-759.
4. Hurtwitz SJ, Coleman CN, Riese N, Loeffler JS, Alexander E, Buswell L, Neben TY, Shargel L, Kramer RA 1992. Distribution of Etanidazole into human brain tumors-implications for treating high grade gliomas. Int J Radiat Oncol Biol Phys 22: 573-576.
5. Lord EM, Harwell L, Koch CJ 1993. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res 53: 5721-5726.
6. Marcus KJ, Dutton, MPH, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NT 2003. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Int J Radiat Oncol Biol Phys 55: 1182-1185.
7. Meletiades J, Mouton, JW, Meis JFGM, Bouman BA, Donnelly JP, Verweij PE, Eurofund Network 2001. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol 39: 3402-3408.
8. Riese NE, Loeffler JS, Wen P, Alexander E, Black PM, Coleman CN 1994. A phase I study of etanidazole and radiotherapy in malignant glioma. Int J Radiat Oncol Biol Phys 29: 617-620.
9. Urbina JA 1999. Chemotherapy of Chagas' disease: the how and the why. J Mol Med 77: 332-338.
10. Wasserman TH, Lee DJ, Cosmatos D, Coleman N, Phillips T, Davis L, Marcial V, Stetz J 1991. Clinical trials with etanidazole (SR-2508) by the Radiation Therapy Oncology Group (RTOG). Radiother Oncol 20 (Suppl.1): 129-135.
11. WHO 1999. Technical Report Series. Document OPS/ HCP/HCT/140.
12. WHO 2000. Special Programme for Research and Training in Tropical Disease (TDR). Natural products for parasitic diseases. TDR News 62: 4.